Low-dose CT lung cancer screening played a prominent role at the annual Screening and Care Conference, sponsored by Go2Foundation for Lung Cancer Screening, November 14 to 15, in Washington, DC.
Physicians, nurses, social workers and other health care professionals (including administrators) who provide lung cancer screening and treatment attended an opening session featuring a four-minute patient educational video on low-dose CT screening.
The “Screening Saves Lives” video and related brochure inform eligible patients about the risks and benefits of low dose CT. They can be useful during the shared decision-making component of lung cancer screening.
After this strong start, the two-day conference revolved around achieving five learning objectives:
- Identify at least three ways to improve patient and provider knowledge and awareness about lung cancer screening in a continuum of care;
- Outline at least three approaches to address coverage gaps and decrease barriers for patients eligible for lung cancer screening;
- Create a strategy to effectively manage patients with both screen-detected and incidentally found nodules and appropriately engage a multidisciplinary evaluation;
- Identify at least two new advancements in diagnostics and/or treatment that can contribute to improved patient outcomes; and
- Identify at least three practical steps that can be taken to improve the participants’ lung cancer screening and care programs.
The American College of Radiology® (ACR®) helped address these themes with presentations by Debra Dyer, MD, FACR, chair of the ACR Lung Cancer Screening (LCS) 2.0 Steering Committee, Mythreyi Chatfield, Ph.D., ACR executive vice-president for quality and safety and Judy Burleson, senior director of quality management programs.
Topics discussed also included LCS incidental findings management and updates to LungRADS® 1.1. Attendees visiting the ACR table for information learned about participation in the College’s Lung Cancer Screening Registry and LCS Center Designation.
In preparation for the conference, ACR lung cancer screening leaders and staff prepared a Quick Reference Guide for front-line lung cancer screening advocates. It answers commonly asked questions about lung cancer screening logistics, program requirements, economics and billing.
Additionally, the meeting confirmed that access to affordable screening services can make a critical difference in the lives of individuals at risk for lung cancer. However, health insurance coverage for screening services can vary widely between insurance programs and individual insurers. The LuCa (Lung Cancer) National Training Network and the Center for Health Law and Policy Innovation of Harvard Law School developed Lung Cancer Screening: Understanding Medicaid, Medicare, and Private Insurance Coverage to help health care providers, patients and advocates navigate this complex coverage landscape.
For more information, see the ACR Lung Cancer Screening Resources webpage.